Emergent BioSolutions reacts to BARDA’s Request for Proposal cancellation
by Nick Rees on December 8, 2009
Fuad El-Hibri
The Office of the Biomedical Advanced Research and Development Authority has advised Emergent BioSolutions that while BARDA’s Request for Proposal has been canceled, Emergent is encouraged to submit a proposal for the office’s Broad Agency Announcement.
BARDA canceled the RFP for the procurement for rPA vaccines after [...]
In: BARDA, Centers for Disease Control and Prevention, Emergent Bioslutions, Federal government of the United States, Fuad El-Hibri, U.S. Food and Drug Administration · Tagged with: Biomedical Advanced Research and Development Authority, Centers for Disease Control and Prevention, Emergent BioSolutions, Federal government of the United States, Fuad El-Hibri, National security, Strategic National Stockpile, United States
Bad News Clouds Two Bio Defense Stocks
Written by Staff and Wire Reports
Tuesday, 08 December 2009 01:28
Key news developments will affect shares of these two companies who help meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons.
The two companies which waited until late after hours on Monday to announce [...]
In: Chief Executive Officer, Emergent Bioslutions, Federal government of the United States, Fuad El-Hibri, Strategic National Stockpile · Tagged with: Biomedical Advanced Research and Development Authority, Centers for Disease Control and Prevention, Federal government of the United States, Fuad El-Hibri, Project Bioshield Act, Strategic National Stockpile, United States, United States Department of Health and Human Services
EMERGENT BIOSOLUTIONS ANNOUNCES EXPANSION OF BOARD OF DIRECTORS AND APPOINTMENT OF DR. SUE BAILEY TO THE COMPANY’S BOARD OF DIRECTORS
ROCKVILLE, MD, June 15, 2007—Emergent BioSolutions Inc. (NYSE: EBS), a biopharmaceutical company, announced today that at a regularly scheduled meeting of its board of directors the board passed a resolution authorizing the expansion of the total number of members of the board to eight. The board also unanimously appointed Sue Bailey, M.D., as a Class [...]
In: Uncategorized · Tagged with: Federal government of the United States, Johns Hopkins University, Medicine, United States, United States armed forces, United States Secretary of Defense, US Food and Drug Administration, US government
Emergent BioSolutions Anticipates 2nd Quarter BioThrax Revenues of Approximately $20 Million Based on Accelerated Delivery to Department of Defense.
Company Preparing Response to DoD Request for Proposal for Delivery of Up to 14 Million Additional Doses of BioThrax
ROCKVILLE, Md. — Emergent BioSolutions Inc. (NYSE:EBS), a biopharmaceutical company, announced today that, pursuant to the terms of an amended contract with the U.S. Departmentof Defense (DoD), it anticipates completing delivery of 900,000 doses of BioThrax([R]) (Anthrax [...]
In: Uncategorized · Tagged with: Anthrax vaccines, Chief executive officer, Emergent BioSolutions, Federal government of the United States, Immunization, United States, United States Department of Defense, US government